Could young Athletes' plasma slow Alzheimer's?
NCT ID NCT05068830
First seen Apr 17, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This study tests whether monthly transfusions of plasma from young, healthy, and fit donors are safe and can improve memory and brain function in people with early Alzheimer's disease. Sixty participants aged 50-75 will receive either the plasma or a saltwater placebo over a year. The goal is to see if exercise-induced changes in blood can benefit the brain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Neurology and Clinical Neurophysiology, St Olavs Hospital
Trondheim, Norway
Conditions
Explore the condition pages connected to this study.